Introducción: Son escasos los datos del impacto de la infección por el virus de inmunodeficiencia humana (VIH) a nivel hormonal, metabólico y hematológico en pacientes hospitalizados en Colombia. Objetivo: Describir el perfil hormonal, metabólico y hematológico de los pacientes con VIH hospitalizados en una institución de tercer nivel. Material y método: Estudio observacional de corte transversal, donde se incluyeron variables sociodemográficas, clínicas, hormonales, metabólicas y hematológicas de pacientes con VIH entre el 2013 y 2014. Resultados: Se incluyeron 52 pacientes, 34 hombres, con media de edad 39,7 años (Ds 12,6, Min: 21 Max: 79). 23% habían cursado con tuberculosis, 13% con toxoplasmosis cerebral. 26 pacientes tenían historia de consumo de tóxicos: cigarrillo (58%), alcohol (27%) y sustancias alucinógenas (15%). 14% de los pacientes recibían terapia antirretroviral al ingreso, los esquemas contenían principalmente inhibidores de proteasa. Otros medicamentos usados fueron: trimetoprim-sulfametoxazol (27.2%) y antituberculosos (15%). Las principales causas de hospitalización fueron toxoplasmosis cerebral (31%) y tuberculosis (15%). 52% de la población presentó síndrome de desgaste. El tiempo de diagnóstico del VIH fue <1 de un año en el 48% de la población. 79% de los pacientes tenía recuento de CD4 <200cel/mm 3 (Ds 199, Min: 3 Max: 641). En el perfil hormonal, 58% (29 pacientes) presentaron alteración del eje tiroideo, de los cuales 14 presentaron perfil de hipotiroidismo central. 55,8% de los hombres presentaron hiperprolactinemia. El perfil metabólico se caracterizó por hipertrigliceridemia (44%) y HDL bajas (81%). La alteración electrolítica de mayor frecuencia fue hiponatremia (37%). Conclusiones: En la población de pacientes hospitalizados con VIH, se encontraron alteraciones endocrinas que sugieren compromiso glandular primario hipofisiario y adrenal; alteraciones lipídicas y electrolíticas en gran medida relacionadas con enfermedad avanzada.
Experience of angioplasty in lower limbs in peripheral arterial disease in a private clinic in southern Colombia Aim: Evaluate the characteristics of patients undergoing angioplasty in the lower limbs, as well as to establish possible associations between the factors leading to complications. Materials and Method: Observational descriptive, cross-sectional and retrospective study conducted during 18 months in which patients with peripheral arterial disease undergoing angioplasty of the lower limb were included, as well their demographic, clinical, and surgical characteristics and the postoperative complications. Results: 158 records of patients between 30 and 95 years were evaluated. 65.2% (n = 103) of the procedures were performed not urgently, the most frequently intervened vessels were the superficial femoral artery (64%), the most frequent type of endovascular intervention was the combination of balloon + medicated ball (32.9%), the most used postoperative pharmacological treatment was the combination of acetylsalicylic acid (ASA) and clopidogrel (86.1%). There were 21 cases of complications, the most frequent complication was minor amputation (52%). A higher risk of minor amputation was found when the surgical procedure was performed urgently (p = 0.012, OR [95% CI]: 4.8 [1.4-16.5]). Discusion: The post-angioplasty complication with statistically significant difference was minor amputation when the procedure was performed urgently, this association was related to the clinical status of the patient at the time of admission and not to the surgical procedure. Conclusion: Angioplasty performed urgently is as safe as elective procedures, given by the same proportion of bleeding or arterial dissection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.